{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T14:17:00Z","timestamp":1790691420682,"version":"4.1.0"},"reference-count":27,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T00:00:00Z","timestamp":1773273600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,8,31]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>Although clinical remission is the primary treatment goal in rheumatoid arthritis (RA), many patients continue to experience residual symptoms that impair quality of life. This study examined whether the complete absence of residual symptoms, assessed using the Okomarigoto Sheet (OS), is associated with achieving the Patient Acceptable Symptom State (PASS), including among patients in Simplified Disease Activity Index (SDAI)-defined remission.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This cross-sectional, single-center study included 260 consecutive patients with RA. Residual symptoms were evaluated using the OS, with particular emphasis on whether an OS score of zero was associated with PASS achievement. Clinical characteristics were compared between groups, and factors associated with PASS non-achievement were analysed using univariate and multivariate logistic regression analyses.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Of the 260 patients, 196 achieved PASS. An OS score of zero was strongly associated with PASS achievement (odds ratio [OR], 11.02; 95% confidence interval [CI], 4.06\u201329.2; P\u2009&amp;lt;\u2009.001). Among patients in SDAI remission, none of the PASS nonachievers had an OS score of zero. PASS nonachievement was associated with higher disease activity, greater functional impairment, and persistent residual symptoms. Multivariate analysis identified Steinbrocker class, C-reactive protein, and total OS score (OR, 1.27; 95% CI, 1.13\u20131.43; P\u2009&amp;lt;\u2009.001) as independent predictors of PASS nonachievement. In patients in SDAI remission, OS-assessed pain independently predicted PASS nonachievement.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The complete absence of residual symptoms, as measured by the OS, was strongly associated with achieving PASS, even among patients in SDAI-defined remission. Systematic evaluation and targeted management of residual symptoms may improve patient satisfaction and facilitate shared decision-making in RA care.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/mr\/roag027","type":"journal-article","created":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T13:02:52Z","timestamp":1773234172000},"page":"753-759","source":"Crossref","is-referenced-by-count":2,"title":["Assessment of residual symptoms using the Okomarigoto Sheet can complement evaluation of the patient acceptable symptom state in patients with rheumatoid arthritis"],"prefix":"10.1093","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6680-3445","authenticated-orcid":false,"given":"Kensuke","family":"Koyama","sequence":"first","affiliation":[{"name":"Department of Rheumatology, Nirasaki City Hospital , Nirasaki, Yamanashi ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuro","family":"Ohba","sequence":"additional","affiliation":[{"name":"Department of Orthopedic Surgery, Faculty of Medicine, University of Yamanashi , Yamanashi ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryousuke","family":"Koizumi","sequence":"additional","affiliation":[{"name":"Department of Orthopedic Surgery, Faculty of Medicine, University of Yamanashi , Yamanashi ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koki","family":"Watabe","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Nirasaki City Hospital , Nirasaki, Yamanashi ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chikako","family":"Sugita","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Nirasaki City Hospital , Nirasaki, Yamanashi ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirotaka","family":"Haro","sequence":"additional","affiliation":[{"name":"Department of Orthopedic Surgery, Faculty of Medicine, University of Yamanashi , Yamanashi ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,3,12]]},"reference":[{"key":"2026083106414598600_ref1","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1136\/ard-2022-223356","article-title":"EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update","volume":"82","author":"Smolen","year":"2023","journal-title":"Ann Rheum Dis"},{"key":"2026083106414598600_ref2","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1093\/mr\/roac017","article-title":"Drug treatment algorithm and recommendations from the 2020 update of the Japan College of Rheumatology clinical practice guidelines for the management of rheumatoid arthritis-secondary publication","volume":"33","author":"Kawahito","year":"2023","journal-title":"Mod Rheumatol"},{"key":"2026083106414598600_ref3","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1002\/acr.23112","article-title":"Do short and sustained periods of American College of Rheumatology\/European league against rheumatism remission predict functional and radiographic outcome in early rheumatoid arthritis patients with low overall damage progression?","volume":"69","author":"Konijn","year":"2017","journal-title":"Arthritis Care Res"},{"key":"2026083106414598600_ref4","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1007\/s10067-020-05451-3","article-title":"Clinical conditions needed to acquire sustained functional remission in rheumatoid arthritis patients","volume":"40","author":"Koizumi","year":"2021","journal-title":"Clin Rheumatol"},{"key":"2026083106414598600_ref5","doi-asserted-by":"crossref","first-page":"3497","DOI":"10.1007\/s10067-025-07592-9","article-title":"Prevalence and predictors of residual symptoms in rheumatoid arthritis patients in SDAI remission: a cross-sectional study using the illustrated okomarigoto sheet","volume":"44","author":"Koyama","year":"2025","journal-title":"Clin Rheumatol"},{"key":"2026083106414598600_ref6","doi-asserted-by":"crossref","first-page":"5073","DOI":"10.1093\/rheumatology\/keab398","article-title":"Current favourable 10-year outcome of patients with early rheumatoid arthritis: data from the ESPOIR cohort","volume":"60","author":"Combe","year":"2021","journal-title":"Rheumatology."},{"key":"2026083106414598600_ref7","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1093\/rheumatology\/keae544","article-title":"Difficult-to-treat rheumatoid arthritis: what have we learned and what do we still need to learn?","volume":"64","author":"Hofman","year":"2025","journal-title":"Rheumatology."},{"key":"2026083106414598600_ref8","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1007\/s00296-023-05349-8","article-title":"Difficult to treat rheumatoid arthritis in a comprehensive evaluation program: frequency according to different objective evaluations","volume":"43","author":"Garcia-Salinas","year":"2023","journal-title":"Rheumatol Int"},{"key":"2026083106414598600_ref9","doi-asserted-by":"crossref","first-page":"4681","DOI":"10.1093\/rheumatology\/keab078","article-title":"Healthcare utilization and economic burden of difficult-to-treat rheumatoid arthritis: a cost-of-illness study","volume":"60","author":"Roodenrijs","year":"2021","journal-title":"Rheumatology."},{"key":"2026083106414598600_ref10","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1136\/annrheumdis-2020-217344","article-title":"EULAR definition of difficult-to-treat rheumatoid arthritis","volume":"80","author":"Nagy","year":"2021","journal-title":"Ann Rheum Dis"},{"key":"2026083106414598600_ref11","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1080\/14397595.2017.1416940","article-title":"Residual symptoms and disease burden among patients with rheumatoid arthritis in remission or low disease activity: a systematic literature review","volume":"28","author":"Ishida","year":"2018","journal-title":"Mod Rheumatol"},{"key":"2026083106414598600_ref12","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1093\/mr\/roac152","article-title":"Illustrations of rheumatoid arthritis symptoms to promote communication between patients and physicians","volume":"34","author":"Kaneko","year":"2023","journal-title":"Mod Rheumatol"},{"key":"2026083106414598600_ref13","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/s41584-020-00541-7","article-title":"Persistent inflammatory and non-inflammatory mechanisms in refractory rheumatoid arthritis","volume":"17","author":"Buch","year":"2021","journal-title":"Nat Rev Rheumatol"},{"key":"2026083106414598600_ref14","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1002\/art.22469","article-title":"Evaluation and validation of the patient acceptable symptom state (PASS) in patients with ankylosing spondylitis","volume":"57","author":"Maksymowych","year":"2007","journal-title":"Arthritis Rheum"},{"key":"2026083106414598600_ref15","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1007\/s10067-019-04860-3","article-title":"Factors associated with and cutoff points for patient acceptable symptom state (PASS) in rheumatoid arthritis","volume":"39","author":"Katchamart","year":"2020","journal-title":"Clin Rheumatol"},{"key":"2026083106414598600_ref16","first-page":"e79473","article-title":"Potential of a novel patient-reported outcome assessment method utilizing illustrations in rheumatoid arthritis","volume":"17","author":"Koyama","year":"2025","journal-title":"Cureus."},{"key":"2026083106414598600_ref17","doi-asserted-by":"crossref","first-page":"26","DOI":"10.3899\/jrheum.090449","article-title":"Identification of cutpoints for acceptable health status and important improvement in patient-reported outcomes, in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis","volume":"37","author":"Kvamme","year":"2010","journal-title":"J Rheumatol"},{"key":"2026083106414598600_ref18","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1002\/acr.21747","article-title":"Minimum clinically important improvement and patient acceptable symptom state in pain and function in rheumatoid arthritis, ankylosing spondylitis, chronic back pain, hand osteoarthritis, and hip and knee osteoarthritis: results from a prospective multinational study","volume":"64","author":"Tubach","year":"2012","journal-title":"Arthritis Care Res"},{"key":"2026083106414598600_ref19","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1001\/jama.1949.02900430001001","article-title":"Therapeutic criteria in rheumatoid arthritis","volume":"140","author":"Steinbrocker","year":"1949","journal-title":"JAMA J Am Med Assoc"},{"key":"2026083106414598600_ref20","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1136\/ard.2007.077503","article-title":"Identification of disease activity and health status cut-off points for the symptom state acceptable to patients with rheumatoid arthritis","volume":"67","author":"Heiberg","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"2026083106414598600_ref21","doi-asserted-by":"crossref","first-page":"930756","DOI":"10.1155\/2015\/930756","article-title":"Patient acceptable symptom state in self-report questionnaires and composite clinical disease index for assessing rheumatoid arthritis activity: identification of cut-off points for routine care","volume":"2015","author":"Salaffi","year":"2015","journal-title":"Biomed Res Int"},{"key":"2026083106414598600_ref22","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1007\/s10067-016-3246-5","article-title":"Predictors of remission, erosive disease and radiographic progression in a Colombian cohort of early onset rheumatoid arthritis: a 3-year follow-up study","volume":"35","author":"Quintana-Duque","year":"2016","journal-title":"Clin Rheumatol"},{"key":"2026083106414598600_ref23","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1080\/03007995.2019.1658974","article-title":"Economic burden of fatigue or morning stiffness among patients with rheumatoid arthritis: a retrospective analysis from real-world data","volume":"36","author":"Strand","year":"2020","journal-title":"Curr Med Res Opin"},{"key":"2026083106414598600_ref24","first-page":"1725","article-title":"PASSing to the patient side: early achieving of an acceptable symptom state in patients with rheumatoid arthritis treated with Janus kinase inhibitors","volume":"77","author":"Garufi","year":"2025","journal-title":"Reumatismo."},{"key":"2026083106414598600_ref25","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1007\/s10067-025-07331-0","article-title":"Residual pain and fatigue are affected by disease perception in rheumatoid arthritis in sustained clinical and ultrasound remission","volume":"44","author":"Perniola","year":"2025","journal-title":"Clin Rheumatol"},{"key":"2026083106414598600_ref26","doi-asserted-by":"crossref","first-page":"2784","DOI":"10.1002\/art.22052","article-title":"Measuring function in rheumatoid arthritis: identifying reversible and irreversible components","volume":"54","author":"Aletaha","year":"2006","journal-title":"Arthritis Rheum"},{"key":"2026083106414598600_ref27","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1590\/1806-9282.20220600","article-title":"Depression as a major determinant of PASS (Patient's acceptable symptoms state) in rheumatoid arthritis: a cross-sectional study in Brazilian patients","volume":"68","author":"Stocker","year":"1992","journal-title":"Rev Assoc Med Bras"}],"container-title":["Modern Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/mr\/advance-article-pdf\/doi\/10.1093\/mr\/roag027\/67317812\/roag027.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/mr\/article-pdf\/36\/5\/753\/67317812\/roag027.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/mr\/article-pdf\/36\/5\/753\/67317812\/roag027.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T10:42:01Z","timestamp":1788172921000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/mr\/article\/36\/5\/753\/8516505"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,12]]},"references-count":27,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,3,12]]},"published-print":{"date-parts":[[2026,8,31]]}},"URL":"https:\/\/doi.org\/10.1093\/mr\/roag027","relation":{},"ISSN":["1439-7595","1439-7609"],"issn-type":[{"value":"1439-7595","type":"print"},{"value":"1439-7609","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,9]]},"published":{"date-parts":[[2026,3,12]]}}}